Anticoagulant thrombolytic therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Iliac Vein Blood Platelets Coronary Vessels Brain Middle Cerebral Artery Carotid Artery, Internal

Organisms2

Diseases49

Myocardial Infarction Pulmonary Embolism Stroke Thrombosis Brain Ischemia Cerebral Hemorrhage Hemorrhage Acute Disease Venous Thrombosis Intracranial Hemorrhages Thromboembolism Intracranial Thrombosis Heart Rupture, Post-Infarction Recurrence Intracranial Embolism and Thrombosis Carotid Artery Thrombosis Coronary Thrombosis Thrombophlebitis Intracranial Embolism Cerebral Infarction Emergencies Cerebrovascular Disorders Eye Hemorrhage Heart Rupture Embolism Arterial Occlusive Diseases Antiphospholipid Syndrome Ecchymosis Infarction, Middle Cerebral Artery Shock, Cardiogenic Ventricular Septal Rupture Heart Diseases Infarction, Anterior Cerebral Artery Thrombophilia Blood Coagulation Disorders Venous Thromboembolism Ventricular Dysfunction, Right Atrial Fibrillation Heart Block Activated Protein C Resistance Disease Models, Animal Hematoma Coronary Disease Ischemic Attack, Transient Ischemia Protein C Deficiency Arrhythmias, Cardiac Constriction, Pathologic Protein S Deficiency

Chemicals and Drugs61

Anticoagulants Streptokinase Fibrinolytic Agents Tissue Plasminogen Activator Plasminogen Activators Heparin Anistreplase Urokinase-Type Plasminogen Activator Lupus Coagulation Inhibitor Warfarin Protein C Recombinant Proteins Fibrinolysin Rodenticides Antithrombins Acenocoumarol Factor Xa Thrombin Phenindione 4-Hydroxycoumarins Aspirin Fibrin Fibrinopeptide A Fibrinogen Hirudins Creatine Kinase Heparin, Low-Molecular-Weight Protein S Platelet Aggregation Inhibitors Blood Coagulation Factors Fibrin Fibrinogen Degradation Products Thrombomodulin beta-Alanine Prothrombin Streptodornase and Streptokinase Antithrombin III Vitamin K Plasminogen Phenprocoumon Antibodies, Antiphospholipid Antifibrinolytic Agents Antibodies, Anticardiolipin Heparin Antagonists Enoxaparin Thromboplastin Factor X Factor V Coagulants beta 2-Glycoprotein I Dicumarol Factor Va Pipecolic Acids Thiophenes Immunoglobulin Fab Fragments Thallium Radioisotopes Vitamin K Epoxide Reductases Dermatan Sulfate Heparin Cofactor II Benzimidazoles Pyridones Metoprolol

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Thrombolytic Therapy Treatment Outcome Myocardial Reperfusion Embolectomy Prothrombin Time Partial Thromboplastin Time Electrocardiography Prospective Studies Angioplasty, Balloon, Coronary Infusions, Intravenous Blood Coagulation Tests Hirudin Therapy Injections, Intravenous Tomography, X-Ray Computed Coronary Angiography Retrospective Studies Infusions, Intra-Arterial Thrombin Time Follow-Up Studies Emergency Treatment International Normalized Ratio Thrombectomy Radionuclide Ventriculography Risk Factors Cerebral Angiography Hospital Mortality Injections, Intra-Arterial Randomized Controlled Trials as Topic Reperfusion Patient Selection Drug Therapy, Combination Catheterization, Peripheral Angiography Survival Analysis Predictive Value of Tests Prognosis Vena Cava Filters Cardiac Catheterization Registries Survival Rate Heart Valve Prosthesis Multivariate Analysis Administration, Oral Incidence Clinical Trials as Topic Severity of Illness Index Catheterization Hospitalization Drug Administration Schedule Magnetic Resonance Imaging Double-Blind Method Stroke Volume Risk Assessment Logistic Models Angioplasty, Balloon Treatment Failure Disease Models, Animal Magnetic Resonance Angiography Echocardiography Intra-Aortic Balloon Pumping Sensitivity and Specificity Fibrin Clot Lysis Time Length of Stay Combined Modality Therapy Cohort Studies Risk Bleeding Time Ultrasonic Therapy Stents Tomography, Emission-Computed, Single-Photon Regression Analysis Ultrasonography, Doppler, Transcranial Coronary Artery Bypass Feasibility Studies Diffusion Magnetic Resonance Imaging Neurologic Examination Pilot Projects

Phenomena and Processes17

Blood Coagulation Time Factors Fibrinolysis Prothrombin Time Partial Thromboplastin Time Vascular Patency Thrombin Time Hemostasis Platelet Aggregation Ventricular Function, Left Stroke Volume Coronary Circulation Sensitivity and Specificity Cerebrovascular Circulation Fibrin Clot Lysis Time Risk Bleeding Time

Disciplines and Occupations1

Community Medicine

Information Science4

Hospital Mortality Registries Survival Rate Incidence

Named Groups1

Emergency Medical Technicians

Health Care40

Treatment Outcome Coronary Care Units Prospective Studies Emergency Medical Services Retrospective Studies Emergencies Follow-Up Studies Emergency Medical Technicians Risk Factors Hospital Mortality Randomized Controlled Trials as Topic Patient Selection Survival Analysis Predictive Value of Tests Hospitals, Community Registries Survival Rate Multivariate Analysis Incidence Clinical Trials as Topic Severity of Illness Index Hospitalization Double-Blind Method Age Factors Risk Assessment Logistic Models Emergency Service, Hospital Drug Utilization Treatment Failure Rodent Control Sensitivity and Specificity Physician's Practice Patterns Length of Stay Cohort Studies Risk Practice Guidelines as Topic Confounding Factors (Epidemiology)Regression Analysis Feasibility Studies Pilot Projects

Geographicals1

Newfoundland and Labrador

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Thrombolytic Therapy Anticoagulants Streptokinase Fibrinolytic Agents Tissue Plasminogen Activator Myocardial Infarction Plasminogen Activators Heparin Anistreplase Pulmonary Embolism Stroke Urokinase-Type Plasminogen Activator Thrombosis Blood Coagulation Brain Ischemia Treatment Outcome Cerebral Hemorrhage Hemorrhage Time Factors Lupus Coagulation Inhibitor Myocardial Reperfusion Embolectomy Acute Disease Fibrinolysis Warfarin Venous Thrombosis Prothrombin Time Coronary Care Units Intracranial Hemorrhages Protein C Thromboembolism Partial Thromboplastin Time Intracranial Thrombosis Heart Rupture, Post-Infarction Electrocardiography Prospective Studies Recurrence Intracranial Embolism and Thrombosis Carotid Artery Thrombosis Angioplasty, Balloon, Coronary Recombinant Proteins Infusions, Intravenous Fibrinolysin Coronary Thrombosis Blood Coagulation Tests Rodenticides Antithrombins Acenocoumarol Thrombophlebitis Hirudin Therapy Injections, Intravenous Tomography, X-Ray Computed Factor Xa Thrombin Coronary Angiography Phenindione 4-Hydroxycoumarins Emergency Medical Services Vascular Patency Aspirin Retrospective Studies Intracranial Embolism Cerebral Infarction Fibrin Emergencies Infusions, Intra-Arterial Thrombin Time Fibrinopeptide A Follow-Up Studies Fibrinogen Hirudins Hemostasis Emergency Treatment International Normalized Ratio Creatine Kinase Heparin, Low-Molecular-Weight Emergency Medical Technicians Protein S Thrombectomy Platelet Aggregation Inhibitors Radionuclide Ventriculography Risk Factors Blood Coagulation Factors Cerebral Angiography Hospital Mortality Injections, Intra-Arterial Randomized Controlled Trials as Topic Fibrin Fibrinogen Degradation Products Reperfusion Cerebrovascular Disorders Thrombomodulin beta-Alanine Patient Selection Drug Therapy, Combination Eye Hemorrhage Catheterization, Peripheral Prothrombin Angiography Survival Analysis Newfoundland and Labrador

No FAQ available that match "anticoagulant thrombolytic therapy"